Search results
Novavax Unusual Options Activity For May 23 - Novavax (NASDAQ:NVAX)
Benzinga· 13 hours agoThe company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly ...
3 Things You Need to Know If You Buy Novavax Today | The Motley Fool
The Motley Fool· 2 days agoNovavax (NVAX 5.30%) stock has both soared and plummeted at times in recent years. Investors...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
The Motley Fool via AOL· 5 days agoVaccine maker Novavax (NASDAQ: NVAX) isn't dead in the water after all. Though the past 18 months have been tough -- and management warned investors that ...
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 2 days agoWhich of these two biotechs can outperform the other moving forward? Let's take a look. NVAX data by YCharts The case for Novavax Novavax earned approval...
Why Novavax (NVAX) Stock Price Appreciated 14% on Monday
Zacks via Yahoo Finance· 3 days agoNovavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company....
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks via Yahoo Finance· 16 hours agoThe Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE)...
The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom
InvestorPlace· 20 hours agoNovavax (NASDAQ:NVAX) stock was among the laggards in the race for the vaccine against COVID-19....
COVID’s New ‘FLiRT’ Variants—What To Know As Experts Fear Summer Surge
Forbes· 2 days agoNew coronavirus variants dubbed “FLiRT” are circulating the world and growing dominant in the U.S.,...
Could Novavax Become the Next Moderna?
The Motley Fool via AOL· 7 days agoImages. Novavax's $1.2 billion deal Last week, Novavax announced a $1.2 billion partnership with Sanofi. The pharmaceutical giant will pay Novavax ...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 4 days agovaccine makers say that the Food and Drug Administration’s delay in designing this fall’s Covid-19 ...